期刊文献+

ER、PR及PCNA在子宫内膜增生过长和内膜腺癌中的表达 被引量:2

Expression of Estrogen Receptor, Progesterone Receptor and Proliferating Cell Nuclear Antigen in Hyperplasia and Adenocarcinoma of Endometrium
下载PDF
导出
摘要 为了探讨女性激素在子宫内膜腺癌和子宫内膜增生过长发病中的作用,为临床内分泌治疗提供理论依据,作者采用免疫组织化学SP法,对手术切除和诊刮的17例子宫内膜腺癌和40例子宫内膜增生过长标本进行ER、PR和PCNA含量检测,并结合组织学类型和分化程度进行分析。结果显示内膜腺癌组织中ER、PR的含量低于增生期和增生过长内膜组织(P<0.05),与肿瘤的组织学类型和分化有关。PCNA在子宫内膜腺癌中的含量显著高于非肿瘤性内膜组织(P<0.01),与分化程度呈负相关。与ER、PR的含量无明显相关性。结果表明ER在子宫内膜增生过长和内膜腺癌的发病中起重要作用,PCNA的过度表达可能与细胞的异常生长和分化有关。 In order to investigate the role of female sex steroid hormones in the pathogenesis of endometrial adenocarcinoma and endometrial hyperplasia and provide theoretical basis for endocrine therapy,the contents of estrogen receptor (ER),progesterone receptor (PR),and proliferating cell nuclear antigen (PCNA) were determined by immunohistochemical SP method in specimens of endometrial adenocarcinoma (17 cases) and endometrial hyperplasia (40 cases) obtained by hysterctomy and biopsy respecitively the results showed that the contents of ER and PR were significantly lower in endometrial adenocarcinoma than those in the proliferative phase and endometrial hyperplasia (P<0.05) and were related to histologic type and degree of tumor differentiation.The contents of PCNA in adenocacinoma of endometrum were significantly higher than those in the nonneoplastic endometrum (P<0.01),but were negatively correlated to their cell differentiation,while there was no obvious correlation between contents of ER,PR and PCNA.These findings indicate that estrogen may play an important role in pathogenesis of hyperplasia and adenocacinoma of endometrium.The overexpression of PCNA could be correlated to abnormal growth and differentiation in these tissues.
出处 《实用癌症杂志》 1998年第1期24-26,共3页 The Practical Journal of Cancer
关键词 子宫内膜增生 子宫内膜肿瘤 腺癌 ER PR PCNA Estrogen receptor Progesterone receptor Proliferating cell nuclear antigen Endometrial hyperplasia Endometrial adenocarcinoma
  • 相关文献

同被引文献9

  • 1庄小强,袁世珍,王晓怀,赖日权,罗祝泉.大肠肿瘤中抑凋亡基因bcl-2和p53蛋白产物的表达和意义[J].临床与实验病理学杂志,1996,12(1):23-26. 被引量:5
  • 2庄小强,袁世珍,王晓怀,赖日权,罗祝泉.大肠癌表皮生长因子受体和p53蛋白表达与临床病理特征和预后的关系[J].临床与实验病理学杂志,1996,12(3):206-209. 被引量:3
  • 3孙保存,赵秀兰,惠京.大肠癌及其癌前病变中细胞凋亡与细胞增殖间关系的原位观察[J].中华医学杂志,1996,76(11):848-851. 被引量:34
  • 4Prelich G,Stillman B. Goordinated leading and lagging strand synthesis during SV40DNA replication in vitro requires PCNA[J]. Cell,1988,53910 : 117.
  • 5Bravo R,Frank R,Blundell PA,et al. Cyclin/PCNA is the auxiliary protein of DNA polimerase-dalte[J]. Nature,1987,326(6112) : 515.
  • 6Mariani A, Sebo TJ ,Katzmann JA, et al. Pretreatment assessment of prognosticindicatorsin endometrialcancer[J].Am-J-Obstet-Gynecol, 2000,182(6): 1535.
  • 7Silverman MB, Roche PC, Kho RM, et al. Molecular and cytokinetic pretreatment risk assessment in endometrial carcinoma [J]. Crynecol- Oncol, 2000,77 (1) : 1.
  • 8Iwai K,Fukuda K,Hachisuga T,et al. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial cancinoma[J]. Crynecol-Oncol, 1999,72 (3) : 351.
  • 9Heffner HM, Freedman AN, Asirwatham JE, et al.Prognostic significance of p53, PCNA, and c- erb - 2 in endometrial carcinoma[J]. Eur-J-Crynaecol-On-col,1999,20(1) : 8.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部